| Dr Benjamin James Drapcho, MD | |
|
92 Campus Dr Fl 2, Scarborough, ME 04074-7228 | |
| (207) 883-1414 | |
| Not Available |
| Full Name | Dr Benjamin James Drapcho |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Neurology |
| Location | 92 Campus Dr Fl 2, Scarborough, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124523337 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | MD26944 (Maine) | Primary |
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Loyola University Chicago researchers are taking advantage of a quirk in the evolution of fruit fly genes to help develop new weapons against cancer.
Nami Therapeutics Corporation, which gets its name from the Mandarin word for "nano," is committed to using nanotechnologies to make big advances in cancer therapy.
Patients with Middle East Respiratory Syndrome (MERS) develop more severe critical illness and have higher mortality than patients with non-MERS severe acute respiratory infection (SARI), according to investigators involved with the largest study of critically ill patients with MERS.
Studies of the enzyme CTP synthetase in the parasite Trypanosoma brucei have brought researchers at Umeå University in Sweden closer to a cure for African sleeping sickness.
The drug DFMO prevents cancer in laboratory models of lymphoma but fails to kill existing cancerous cells that have lost the ability to self-destruct, according to investigators at St. Jude Children's Research Hospital.
› Verified 4 days ago
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992719272 PECOS PAC ID: 9335043967 Enrollment ID: O20050901000035 |
News Archive
Loyola University Chicago researchers are taking advantage of a quirk in the evolution of fruit fly genes to help develop new weapons against cancer.
Nami Therapeutics Corporation, which gets its name from the Mandarin word for "nano," is committed to using nanotechnologies to make big advances in cancer therapy.
Patients with Middle East Respiratory Syndrome (MERS) develop more severe critical illness and have higher mortality than patients with non-MERS severe acute respiratory infection (SARI), according to investigators involved with the largest study of critically ill patients with MERS.
Studies of the enzyme CTP synthetase in the parasite Trypanosoma brucei have brought researchers at Umeå University in Sweden closer to a cure for African sleeping sickness.
The drug DFMO prevents cancer in laboratory models of lymphoma but fails to kill existing cancerous cells that have lost the ability to self-destruct, according to investigators at St. Jude Children's Research Hospital.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Benjamin James Drapcho, MD 92 Campus Dr Fl 2, Scarborough, ME 04074-7228 Ph: (207) 883-1414 | Dr Benjamin James Drapcho, MD 92 Campus Dr Fl 2, Scarborough, ME 04074-7228 Ph: (207) 883-1414 |
News Archive
Loyola University Chicago researchers are taking advantage of a quirk in the evolution of fruit fly genes to help develop new weapons against cancer.
Nami Therapeutics Corporation, which gets its name from the Mandarin word for "nano," is committed to using nanotechnologies to make big advances in cancer therapy.
Patients with Middle East Respiratory Syndrome (MERS) develop more severe critical illness and have higher mortality than patients with non-MERS severe acute respiratory infection (SARI), according to investigators involved with the largest study of critically ill patients with MERS.
Studies of the enzyme CTP synthetase in the parasite Trypanosoma brucei have brought researchers at Umeå University in Sweden closer to a cure for African sleeping sickness.
The drug DFMO prevents cancer in laboratory models of lymphoma but fails to kill existing cancerous cells that have lost the ability to self-destruct, according to investigators at St. Jude Children's Research Hospital.
› Verified 4 days ago
Dr. Jason Alan Helis, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 49 Spring St, Scarborough, ME 04074 Phone: 207-883-1414 | |
Peter Y. Kang, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7 Oak Hill Ter Ste 218, Scarborough, ME 04074 Phone: 207-303-0022 Fax: 207-303-0023 | |
Dr. Jacob Morgan Stout, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 92 Campus Dr, Scarborough, ME 04074 Phone: 207-662-0111 | |
John R Belden, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 49 Spring St, 2nd Floor, Scarborough, ME 04074 Phone: 207-883-1414 Fax: 207-883-1518 | |
Heidi L Henninger, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 49 Spring St, 2nd Floor, Scarborough, ME 04074 Phone: 207-883-1414 Fax: 207-883-1518 | |
Diana Jeanne Goodman, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 49 Spring St, Scarborough, ME 04074 Phone: 207-883-1414 Fax: 207-883-1010 |